![Yu Waye Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yu Waye Chu
Chief Tech/Sci/R&D Officer at
CYTOMX THERAPEUTICS, INC.
Net worth: 107 747 $ as of 30/09/2026
Profile
Yu Waye Chu holds the position of Senior Vice President-Clinical Development at Fate Therapeutics, Inc. He received an undergraduate degree from Princeton University and a doctorate from the University of Rochester School of Medicine & Dentistry.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 39,613 ( 0.02% ) | 107 747 $ | 30/09/2026 |
Yu Waye Chu active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/07/2023 |
Former positions of Yu Waye Chu
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14/07/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/04/2019 |
Education of Yu Waye Chu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
University of Rochester School of Medicine & Dentistry
 University of Rochester School of Medicine & Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Yu Waye Chu
